Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

Institute of Hematology & Blood Diseases Hospital, China · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
severe aplastic anemia, platelet transfusion refractoriness, rituximab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 854588
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.